Cargando…
Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial
BACKGROUND: Reduction of the reservoir of latent HIV-infected cells might increase the possibility of long-term remission in individuals living with HIV. We investigated factors associated with HIV-1 proviral DNA levels in children receiving different antiretroviral therapy (ART) strategies in the c...
Autores principales: | Payne, Helen, Chan, Man K., Watters, Sarah A., Otwombe, Kennedy, Hsiao, Nei-Yuan, Babiker, Abdel, Violari, Avy, Cotton, Mark F., Gibb, Diana M., Klein, Nigel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482761/ https://www.ncbi.nlm.nih.gov/pubmed/34587974 http://dx.doi.org/10.1186/s12981-021-00389-1 |
Ejemplares similares
-
Does early initiation of ART in infants affect virological and resistance outcomes? Data from the CHER trial after 6 years of follow-up
por: Violari, A, et al.
Publicado: (2012) -
Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
por: Lewis, Joanna, et al.
Publicado: (2017) -
Naive B Cell Output in HIV-Infected and HIV-Uninfected Children
por: Payne, Helen, et al.
Publicado: (2019) -
Five year neurodevelopment outcomes of perinatally HIV‐infected children on early limited or deferred continuous antiretroviral therapy
por: Laughton, Barbara, et al.
Publicado: (2018) -
Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study
por: Hainline, Clotilde, et al.
Publicado: (2011)